Skip to Main Content
Table 1

Baseline characteristics, prior treatments, and susceptibility of mononuclear cells from AML patients to infection by VSV-GFP

Baseline characteristics, prior treatments, and susceptibility of mononuclear cells from AML patients to infection by VSV-GFP
Baseline characteristics, prior treatments, and susceptibility of mononuclear cells from AML patients to infection by VSV-GFP
Close Modal

or Create an Account

Close Modal
Close Modal